← FDA Drug Approvals (Drugs@FDA)

RIFADIN

NDA · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1989-05-25

Drug application

FDA Application #
NDA050627
Application type
New Drug Application
Brand name
RIFADIN
Generic name
RIFAMPIN
Active ingredients
RIFAMPIN
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
SANOFI AVENTIS US
Manufacturer
Sanofi-Aventis U.S. LLC
First approval
1989-05-25

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown